Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3703Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | D. Ravi Sankara Reddy | - |
| dc.date.accessioned | 2026-05-05T12:06:10Z | - |
| dc.date.available | 2026-05-05T12:06:10Z | - |
| dc.date.issued | 2026-05-05 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3703 | - |
| dc.description | Vol. 38, No. 2, p443 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | 2,5- diarylsubstituted 1,3,4,- thiadiazole | en_US |
| dc.subject | molecular docking | en_US |
| dc.subject | dynamic simulation | en_US |
| dc.subject | Hypoglycemic activity | en_US |
| dc.title | Therapeutic potential of disubstitited [{ [5- (2-chloro phenyl)-1,3,4 - thiadiazole - 2 - yl}]- methyl] phenyl derivatives as α-amylase antagonists : synthesis in silico and in vitro screening | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 38, No. 2, 2026 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.